Nabavi, S. M., Arab, L., Jarooghi, N., Bolurieh, T., Abbasi, F., Mardpour, S., . . . Aghdami, N. (2019). Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial. Cell J.
Citação norma ChicagoNabavi, Seyed Massood, et al. "Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial." Cell J 2019.
MLA引文Nabavi, Seyed Massood, et al. "Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial." Cell J 2019.